IL10 and neoplasm: A 2021 publication in Nature has identified B cell-derived GABA promotes monocyte differentiation into IL-10(+) macrophages and limits anti-tumor immunity by inhibiting CD8(+) T cell killer function (131), establishing a suppressive TIME via modulating macrophage differentiation.